MedTrace Logo

Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP

NCT03043716 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 14147

Last updated 2024-05-28

No results posted yet for this study

Summary

Telemonitoring for Positive Airway Pressure (PAP) therapy might help to establish and maintain long-term therapy adherence and thus support the beneficial effects of PAP therapy on long-term outcomes.

Conditions

Interventions

OTHER

PAP therapy with telemonitoring

Patients will receive a prescription for PAP therapy in the course of their clinical Routine pathway and afterwards be asked to enrol in the registry. The will be asked if they are willing to use telemonitoring technology.

Sponsors & Collaborators

  • RWTH Aachen University

    collaborator OTHER

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Hartmut Grüger, Dr · Grand Arc Düsseldorf

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03043716 on ClinicalTrials.gov